Novel multifunctional polyethylene glycol-transactivating-transduction protein-modified liposomes cross the blood-spinal cord barrier after spinal cord injury

Journal of Drug Targeting

Volumn 18, Issue 6, 2010, Pages 420-429

  Liu, Yang ^a   Wang, Chun Yuan ^a   Kong, Xiao Hong ^b   Wang, Han Jie ^c   Chang, Jin ^c   Zhang, Da Peng ^a   Ban, De Xiang ^a   Feng, Shi Qing ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b NANKAI UNIVERSITY   (China)

^c TIANJIN UNIVERSITY   (China)

Author keywords

BSCB; Multifunctional liposome; PEG; Rat; SCI; TAT

Indexed keywords

DRUG; FERRIC FERROCYANIDE; IRON; LIPOSOME; MACROGOL; TRANSACTIVATOR PROTEIN; CHITOSAN; CHOLESTEROL; MACROGOL DERIVATIVE; NANOPARTICLE; PEPTIDE; PEPTIDE FRAGMENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PERMEABILITY BARRIER; PRIORITY JOURNAL; RAT; SIGNAL DETECTION; SPINAL CORD INJURY; STAINING; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; CHEMISTRY; DISEASE MODEL; MAGNETISM; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PATHOLOGY; PROCEDURES; SPINAL CORD; SPINAL CORD INJURIES; SURFACE PROPERTY; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE; VASCULARIZATION;

ANIMALS; CHITOSAN; CHOLESTEROL; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; GENE PRODUCTS, TAT; IRON; LIPOSOMES; MAGNETIC RESONANCE IMAGING; MAGNETICS; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; PARTICLE SIZE; PEPTIDE FRAGMENTS; PEPTIDES; POLYETHYLENE GLYCOLS; RATS; SPECTROPHOTOMETRY, ATOMIC; SPINAL CORD; SPINAL CORD INJURIES; SURFACE PROPERTIES;

EID: 77953259592     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/10611860903434001     Document Type: Article

References (40)

1. Abbott NJ. (2002). Astrocyte-endothelial interactions and bloodbrain barrier permeability. J Anat, 200: 629-638.
2. Aktas Y, Yemisci M, Andrieux K, Gürsoy RN, Alonso MJ, Fernandez-Megia E, Novoa-Carballal R, Quiñoá E, Riguera R, Sargon MF, Celik HH, Demir AS, Hincal AA, Dalkara T, Capan Y, Couvreur P. (2005). Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26. Bioconjug Chem, 16: 1503-1511.
3. Barbet J, Machy P, Leserman LD. (1981). Monoclonal antibody covalently coupled to liposomes: specific targeting to cells. J Supramol Struct Cell Biochem, 16: 243-258.
4. Bazile DV, Ropert C, Huve P, Verrecchia T, Marlard M, Frydman A, Veillard M, Spenlehauer G. (1992). Body distribution of fully biodegradable [14C]-poly(lactic acid) nanoparticles coated with albumin after parenteral administration to rats. Biomaterials, 13: 1093-1102.
5. Begley DJ. (2004). Efflux mechanisms in the central nervous system: a powerful influence on drug distribution within the brain. In Sharma HS & Westman J (Eds.), Blood-Spinal Cord and Brain Barriers in Health and Disease (pp. 83-97). San Diego: Elsevier.
6. Begley DJ. (2003). Understanding and circumventing the blood-brain barrier. Acta Paediatr Suppl, 92: 83-91.
7. Borisoff JF, Chan CC, Hiebert GW, Oschipok L, Robertson GS, Zamboni R, Steeves JD, Tetzlaff W. (2003). Suppression of Rho-kinase activity promotes axonal growth on inhibitory CNS substrates. Mol Cell Neurosci, 22: 405-416.
8. Bulte JW, Douglas T, Witwer B, Zhang SC, Strable E, Lewis BK, Zywicke H, Miller B, van Gelderen P, Moskowitz BM, Duncan ID, Frank JA. (2001). Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol, 19: 1141-1147.
9. Carlsson J, Drevin H, Axén R. (1978). Protein thiolation and reversible protein-protein conjugation. N-Succinimidyl 3-(2-pyridyldithio) propionate, a new heterobifunctional reagent. Biochem J, 173: 723-737.
10. Choi UH, Ha Y, Huang X, Park SR, Chung J, Hyun DK, Park H, Park HC, Kim SW, Lee M. (2007). Hypoxia-inducible expression of vascular endothelial growth factor for the treatment of spinal cord injury in a rat model. J Neurosurg Spine, 7: 54-60.
11. Costantino L, Gandolfi F, Tosi G, Rivasi F, Vandelli MA, Forni F. (2005). Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier. J Control Release, 108: 84-96.
12. Geraldes CF, Laurent S. (2009). Classification and basic properties of contrast agents for magnetic resonance imaging. J Contrast Media Mol Imaging, 4: 1-23.
13. Green I, Christison R, Voyce CJ, Bundell KR, Lindsay MA. (2003). Protein transduction domains: are they delivering? Trends Pharmacol Sci, 24: 213-215.
14. Hawrylak N, Ghosh P, Broadus J, Schlueter C, Greenough WT, Lauterbur PC. (1993). Nuclear magnetic resonance (NMR) imaging of iron oxide-labeled neural transplants. Exp Neurol, 121: 181-192.
15. Hurn PD, Lipscomb DC, Gorman LK, Traystman RJ. (1995). Levels of iron during incomplete global ischemia (abstract). Soc Neurosci Abstr, 21: 394.13.
16. Jin K, Mao XO, Greenberg DA. (2006). Vascular endothelial growth factor stimulates neurite outgrowth from cerebral cortical neurons via Rho kinase signaling. J Neurobiol, 66: 236-242.
17. Metselaar JM, Bruin P, de Boer LW, de Vringer T, Snel C, Oussoren C, Wauben MH, Crommelin DJ, Storm G, Hennink WE. (2003). A novel family of L-amino acid-based biodegradable polymer-lipid conjugates for the development of long-circulating liposomes with effective drug-targeting capacity. Bioconjug Chem, 14: 1156-1164.
18. Kaptanoglu E, Caner H, Solaroglu I, Kilinc K. (2005). Mexiletine treatment-induced inhibition of caspase-3 activation and improvement of behavioral recovery after spinal cord injury. J Neurosurg Spine, 3: 53-56.
19. Landry FB, Bazile DV, Spenlehauer G, Veillard M, Kreuter J. (1996). Influence of coating agents on the degradation of poly (lactic acid)nanoparticles in model digestive fluids (USP XXII). STP Pharm Sci, 63: 195-202.
20. Levin VA. (1980). Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability. J Med Chem, 23: 682-684.
21. Liang XF, Wanf HJ, Tian H, Luo H, Chang J. (2008). Syntheis, structure, and properties of novel quaternized carboxymethyl chitosan with drug loading capacity. Acta Phys Chim Sin, 24: 223-229.
22. Liang XF, Wang HJ, Luo H, Tian H, Zhang BB, Hao LJ, Teng JI, Chang J. (2008). Characterization of novel multifunctional cationic polymeric liposomes formed from octadecyl quaternized carboxymethyl chitosan/cholesterol and drug encapsulation. Langmuir, 24: 7147-7153.
23. Liu L, Guo K, Lu J, Venkatraman SS, Luo D, Ng KC, Ling EA, Moochhala S, Yang YY. (2008). Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrier. Biomaterials, 29: 1509-1517.
24. Lovin JD, Wesbey GE, Engelstad BL, Sosnovsky G, Moseley M, Tuck DL, Brasch RC. (1985). Magnetic field dependence of spin-lattice relaxation enhancement using piperidinyl nitroxyl spin-labels. Magn Reson Imaging, 3: 73-81.
25. Lu W, Tan YZ, Hu KL, Jiang XG. (2005). Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood-brain barrier. Int J Pharm, 295: 247-260.
26. Maikos JT, Shreiber DI. (2007). Immediate damage to the bloodspinal cord barrier due to mechanical trauma. J Neurotrauma, 24: 492-507.
27. Martin C, Berridge G, Higgins C, Mistry P, Charlton P, Callaghan R. (2005). Communication between multiple drug binding sites on P-glycoprotein. Mol Pharm, 8: 624-632
28. Mehta JR, Braund KG, Toivio-Kinnucan M. (1990). Elemental composition, water, and total lipid content in peripheral nerves, spinal cord and brain of healthy adult dogs. Res Vet Sci, 49: 250-252.
29. Mu L, Seow PH, Ang SN, Feng SS. (2004). Study on surfactant coating of polymeric nanoparticles for controlled delivery of anticancer drug. J Colloid Polymer Sci, 283: 58-65.
30. Rennels ML, Gregory TF, Fujimoto K. (1983). Innervation of capillaries by local neurons in the cat hypothalamus: a light microscopic study with horseradish peroxidase. J Cereb Blood Flow Metab, 3: 535-542.
31. Richard JP, Melikov K, Vives E, Ramos C, Verbeure B, Gait MJ, Chernomordik LV, Lebleu B. (2003). Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J Biol Chem, 278: 585-590.
32. Scuotto A, Borriello R, Paggio G, D'Avanzo R, Cioffi FA, Sciaudone G. (1984). Valuation of some biological parameters in acute spinal cord trauma: experimental study in rabbits. J Neurosurg Sci, 28: 145-147.
33. Sixt M, Engelhardt B, Pausch F, Hallmann R, Wendler O, Sorokin LM. (2001). Endothelial cell laminin isoforms, laminins 8 and 10, play decisive roles in T cell recruitment across the blood-brain barrier in experimental autoimmune encephalomyelitis. J Cell Biol, 153: 933-946.
34. Torchilin VP, Papisov MI. (1994). Hipotesis: why do polyethylene glycol-coated liposomes circulate so long? J Liposome Res, 4: 725-739.
35. Torchilin VP, Rammohan R, Weissig V, Levchenko TS. (2001). TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc Natl Acad Sci USA, 98: 8786-8791.
36. Wesbey GE, Brasch RC, Goldberg HI, Engelstad BL, Moss AA. (1985). Dilute oral iron solutions as gastrointestinal contrast agents for magnetic resonance imaging; initial clinical experience. Magn Reson Imaging, 3: 57-64.
37. Zaleska MM, Floyd RA. (1985). Regional lipid peroxidation in rat brain in vitro: possible role of endogenous iron. Neurochem Res, 10: 397-410.
38. Zenker D, Begley D, Bratzke H, Rübsamen-Waigmann H, von Briesen H. (2003). Human blood-derived macrophages enhance barrier function of cultured primary bovine and human brain capillary endothelial cells. J Physiol (Lond), 551: 1023-1032.
39. Zhang YD, Li H. (2002). Research advance mentonnano-vector carrys nano-medicine aims for liver. J China J Med Eng, 11: 75-77.
40. Zhang X, Xie J, Li S, Wang X, Hou X. (2003). The study on brain targeting of the amphotericin B liposomes. J Drug Target, 11: 117-122.